GuruFocus.com via Yahoo
Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
How do you plan to monitor for safety and efficacy in this study? A: Robert I. Blum, CEO & President of Cytokinetics, noted that it's premature to announce the design for the Phase 2 study.
3 days ago